Literature DB >> 22454467

Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.

Kendra Viner1, Dana Perella, Adriana Lopez, Stephanie Bialek, Claire Newbern, Rodrerica Pierre, Niya Spells, Barbara Watson.   

Abstract

BACKGROUND: Because the varicella incidence has declined following varicella vaccine licensure, herpes zoster (HZ) cases may play a larger role in varicella zoster virus (VZV) transmission. We investigated how HZ and varicella cases contribute to the varicella incidence in schools and day care centers.
METHODS: Surveillance data collected in Philadelphia during September 2003-June 2010 were analyzed. A varicella case was considered to be sporadic if it was reported from a school or day care facility >6 weeks after or ≥10 days before other reports of VZV transmission. A varicella case was considered to be secondary if it occurred 10-21 days after report of a case of HZ or sporadic varicella. Analysis compared VZV transmission from individuals with HZ or sporadic varicella, stratified by varicella vaccination status and disease severity.
RESULTS: Of 290 HZ cases reported, 27 (9%) resulted in 84 secondary varicella cases. Of 1358 sporadic varicella cases reported, 205 (15%) resulted in 564 secondary varicella cases. Approximately half of the HZ and sporadic varicella cases resulted in single secondary cases. The proportion of individuals who had secondary cases with mild disease was similar for those exposed to HZ and those exposed to varicella (70% and 72%, respectively). VZV transmission was highest from unvaccinated individuals with sporadic varicella (P < .01).
CONCLUSIONS: VZV transmission from individuals with HZ contributes to varicella morbidity. More research is needed to understand risk factors and guide recommendations for preventing VZV transmission from individuals with HZ.

Entities:  

Mesh:

Year:  2012        PMID: 22454467     DOI: 10.1093/infdis/jis207

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Varicella zoster virus transmission in the vaccine era: unmasking the role of herpes zoster.

Authors:  Karen C Bloch; James G Johnson
Journal:  J Infect Dis       Date:  2012-03-27       Impact factor: 5.226

Review 2.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

Review 3.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

4.  Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia.

Authors:  Pieter Meysman; Benson Ogunjimi; Stefan Naulaerts; Philippe Beutels; Viggo Van Tendeloo; Kris Laukens
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

Review 5.  Reducing the burden of Herpes Zoster in Italy.

Authors:  Giovanni Gabutti; Elisabetta Franco; Paolo Bonanni; Michele Conversano; Antonio Ferro; Marzia Lazzari; Stefania Maggi; Alessandro Rossi; Silvestro Scotti; Francesco Vitale; Antonio Volpi; Donato Greco
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 6.  Herpes zoster and postherpetic neuralgia in older adults.

Authors:  Kenneth Schmader
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

7.  Case Report: Various Clinical Manifestations Caused by Varicella-Zoster Virus in a Family.

Authors:  Qinghong Meng; Bingsong Wang; Xianlai Zhang; Zhen Li; Wenjie Wang; Kaihu Yao
Journal:  Front Pediatr       Date:  2022-06-06       Impact factor: 3.569

Review 8.  Varicella-zoster virus post-exposure management and prophylaxis: A review.

Authors:  Anne M Lachiewicz; Megan L Srinivas
Journal:  Prev Med Rep       Date:  2019-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.